Obesity Clinical Trial
— RE-TOOLOfficial title:
Rural Engagement in TelemedTeam for Options in Obesity Treatment Solutions (RE-TOOL)
The purpose of this study is to compare two methods for managing obesity in rural primary care patients. The first method includes quarterly 1:1 meetings with the participant and their primary care provider and the second includes a group lifestyle intervention over Zoom paired with quarterly team meetings with the participant, their primary care provider and their lifestyle coach, the coach joining via Zoom. Investigators will evaluate which method is best at helping participants lose weight over 18 months.
Status | Recruiting |
Enrollment | 560 |
Est. completion date | August 2026 |
Est. primary completion date | August 2026 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 20 Years to 75 Years |
Eligibility | Inclusion Criteria: - BMI: >= 30 kg/m2 - Rural resident - English speaking - Physician clearance to participate - Able to walk without assistance - Seen at least once in their primary care clinic within the past year - Internet access or smart phone (to access smart scale for weight measurement) Exclusion Criteria: - History of myocardial infarction within last six months - History of stroke within last six months - History of new cancer diagnosis within last six months - History of bariatric surgery within the last two years - Pregnancy within last 6 months or planned within the next 18 months - Currently breastfeeding - End stage renal disease, currently on dialysis, or anticipated dialysis or renal transplant within the next 18 months - End stage liver disease, or anticipated liver transplant within the next 18 months - Currently enrolled or planning to enroll in another study where weight loss is targeted or weight fluctuation is expected - Currently planning to move outside of current provider area, or leave primary care clinic within the next 18 months - Another household member is already participating in the study |
Country | Name | City | State |
---|---|---|---|
United States | University of Kansas Medical Center | Kansas City | Missouri |
Lead Sponsor | Collaborator |
---|---|
University of Kansas Medical Center | National Cancer Institute (NCI) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Percent weight loss at 18 months | Mean percent weight loss at 18 months; unadjusted | 18 months | |
Secondary | Percent weight loss at 6 months | Mean percent weight loss at 6 months; unadjusted | 6 months | |
Secondary | Percent weight loss at 12 months | Mean percent weight loss at 12 months; unadjusted | 12 months | |
Secondary | Weight loss (kg) at 6 months | Mean weight loss (kg) at 6 months; unadjusted | 6 months | |
Secondary | Weight loss (kg) at 12 months | Mean weight loss (kg) at 12 months; unadjusted | 12 months | |
Secondary | Weight loss (kg) at 18 months | Mean weight loss (kg) at 18 months; unadjusted | 18 months | |
Secondary | Proportion achieving =5% weight loss at 6 months | Proportion achieving =5% weight loss at 6 months; unadjusted | 6 months | |
Secondary | Proportion achieving =5% weight loss at 12 months | Proportion achieving =5% weight loss at 12 months; unadjusted | 12 months | |
Secondary | Proportion achieving =5% weight loss at 18 months | Proportion achieving =5% weight loss at 18 months; unadjusted | 18 months | |
Secondary | Proportion achieving =10% weight loss at 6 months | Proportion achieving =10% weight loss at 6 months; unadjusted | 6 months | |
Secondary | Proportion achieving =10% weight loss at 12 months | Proportion achieving =10% weight loss at 12 months; unadjusted | 12 months | |
Secondary | Proportion achieving =10% weight loss at 18 months | Proportion achieving =10% weight loss at 18 months; unadjusted | 18 months | |
Secondary | Change in diet quality at 6 months | Mean change in diet quality, measured by Rapid Eating Assessment for Participant--Shortened Version (REAPS) at 6 months; unadjusted. The REAPS estimates diet quality through 13 items which assess weekly eating habits. Possible scores range from 13 (worst diet quality) to 39 (best diet quality). | Baseline and 6 months | |
Secondary | Change in diet quality at 12 months | Mean change in diet quality, measured by Rapid Eating Assessment for Participant--Shortened Version (REAPS) at 12 months; unadjusted. The REAPS estimates diet quality through 13 items which assess weekly eating habits. Possible scores range from 13 (worst diet quality) to 39 (best diet quality). | Baseline and 12 months | |
Secondary | Change in diet quality at 18 months | Mean change in diet quality, measured by Rapid Eating Assessment for Participant--Shortened Version (REAPS) at 18 months; unadjusted. The REAPS estimates diet quality through 13 items which assess weekly eating habits. Possible scores range from 13 (worst diet quality) to 39 (best diet quality). | Baseline and 18 months | |
Secondary | Change in physical activity at 6 months | Mean change in MET-HOURS per week measured by Modifiable Activity Questionnaire (MAQ) at 6 months; unadjusted. The MAQ will be used to measure participants' leisure-time physical activity over the past 7 days. Leisure-time physical activity will be calculated as the Metabolic Equivalent of Task (MET) hours per week (MET-hr/week) and estimated by multiplying time (in hours) spent in an activity by the activities estimated MET and summing across all activities. | Baseline and 6 months | |
Secondary | Change in physical activity at 12 months | Mean change in MET-HOURS per week measured by Modifiable Activity Questionnaire (MAQ) at 12 months; unadjusted. The MAQ will be used to measure participants' leisure-time physical activity over the past 7 days. Leisure-time physical activity will be calculated as the Metabolic Equivalent of Task (MET) hours per week (MET-hr/week) and estimated by multiplying time (in hours) spent in an activity by the activities estimated MET and summing across all activities. | Baseline and 12 months | |
Secondary | Change in physical activity at 18 months | Mean change in MET-HOURS per week measured by Modifiable Activity Questionnaire (MAQ) at 18 months; unadjusted. The MAQ will be used to measure participants' leisure-time physical activity over the past 7 days. Leisure-time physical activity will be calculated as the Metabolic Equivalent of Task (MET) hours per week (MET-hr/week) and estimated by multiplying time (in hours) spent in an activity by the activities estimated MET and summing across all activities. | Baseline and 18 months | |
Secondary | Change in physical quality of life at 6 months | Mean change in physical quality of life, measured by SF-12 at 6 months; unadjusted. The Short Form Health Survey (SF-12) is a general quality of life measure with a physical functioning summary score. Scores range from 0 to 100 with higher scores representing better functioning. | Baseline and 6 months | |
Secondary | Change in physical quality of life at 12 months | Mean change in physical quality of life, measured by SF-12 at 12 months; unadjusted. The Short Form Health Survey (SF-12) is a general quality of life measure with a physical functioning summary score. Scores range from 0 to 100 with higher scores representing better functioning. | Baseline and 12 months | |
Secondary | Change in physical quality of life at 18 months | Mean change in physical quality of life, measured by SF-12 at 18 months; unadjusted. The Short Form Health Survey (SF-12) is a general quality of life measure with a physical functioning summary score. Scores range from 0 to 100 with higher scores representing better functioning. | Baseline and 18 months | |
Secondary | Change in mental quality of life at 6 months | Mean change in mental quality of life, measured by SF-12 at 6 months; unadjusted. The Short Form Health Survey (SF-12) is a general quality of life measure with a mental functioning summary score. Scores range from 0 to 100 with higher scores representing better functioning. | Baseline and 6 months | |
Secondary | Change in mental quality of life at 12 months | Mean change in mental quality of life, measured by SF-12 at 12 months; unadjusted. The Short Form Health Survey (SF-12) is a general quality of life measure with a mental functioning summary score. Scores range from 0 to 100 with higher scores representing better functioning. | Baseline and 12 months | |
Secondary | Change in mental quality of life at 18 months | Mean change in mental quality of life, measured by SF-12 at 18 months; unadjusted. The Short Form Health Survey (SF-12) is a general quality of life measure with a mental functioning summary score. Scores range from 0 to 100 with higher scores representing better functioning. | Baseline and 18 months | |
Secondary | Change in weight-related quality of life at 6 months | Mean change in total quality of life, measured by Impact of Weight on Quality of Life-Lite (IWQOL-L) at 6 months; unadjusted. The IWQOL-L measure consists of a total score and five subscales--physical function, self-esteem, sexual life, public distress, and work. The total score ranges from 0 to 100 with higher scores indicating better quality of life. | Baseline and 6 months | |
Secondary | Change in weight-related quality of life at 12 months | Mean change in total quality of life, measured by Impact of Weight on Quality of Life-Lite (IWQOL-L) at 12 months; unadjusted. The IWQOL-L measure consists of a total score and five subscales--physical function, self-esteem, sexual life, public distress, and work. The total score ranges from 0 to 100 with higher scores indicating better quality of life. | Baseline and 12 months | |
Secondary | Change in weight-related quality of life at 18 months | Mean change in total quality of life, measured by Impact of Weight on Quality of Life-Lite (IWQOL-L) at 18 months; unadjusted. The IWQOL-L measure consists of a total score and five subscales--physical function, self-esteem, sexual life, public distress, and work. The total score ranges from 0 to 100 with higher scores indicating better quality of life. | Baseline and 18 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |